Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew C Rankin

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cardiac Electrophysiology Review|May 2, 2002
Arrhythmias in systemic sclerosis and related disordersAndrew C Rankin
The Practitioner|July 28, 2007
Assessing stroke risk in patients with AFGillian Marshall, Andrew C Rankin
The Practitioner|July 28, 2007
Tackling the QOF2 indicators for AFAndrew C Rankin, Peter Savill
Cardiovascular Research|August 29, 2009
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?Andrew C Rankin, Antony J Workman
Heart Rhythm|April 13, 2010
Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how?Antony J Workman, Andrew C Rankin
Cardiovascular Research|September 23, 2003
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillationAntony J Workman, Kathleen A Kane, Andrew C Rankin
Heart Rhythm|February 10, 2009
Cellular bases for human atrial fibrillationAntony J Workman, Kathleen A Kane, Andrew C Rankin
Postgraduate Medical Journal|July 18, 2015
Auscultating heart and breath sounds through patients' gowns: who does this and does it matter?Alastair J Rankin, Stephen H Rankin, Andrew C Rankin
Journal of Molecular and Cellular Cardiology|September 23, 2006
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillationDavide Pau, Antony J Workman, Kathleen A Kane, et al.
British Journal of Pharmacology|November 19, 2003
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockadeDavide Pau, Antony J Workman, Kathleen A Kane, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cardiac Electrophysiology Review|May 2, 2002
Arrhythmias in systemic sclerosis and related disordersAndrew C Rankin
The Practitioner|July 28, 2007
Assessing stroke risk in patients with AFGillian Marshall, Andrew C Rankin
The Practitioner|July 28, 2007
Tackling the QOF2 indicators for AFAndrew C Rankin, Peter Savill
Cardiovascular Research|August 29, 2009
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?Andrew C Rankin, Antony J Workman
Heart Rhythm|April 13, 2010
Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how?Antony J Workman, Andrew C Rankin
Cardiovascular Research|September 23, 2003
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillationAntony J Workman, Kathleen A Kane, Andrew C Rankin
Heart Rhythm|February 10, 2009
Cellular bases for human atrial fibrillationAntony J Workman, Kathleen A Kane, Andrew C Rankin
Postgraduate Medical Journal|July 18, 2015
Auscultating heart and breath sounds through patients' gowns: who does this and does it matter?Alastair J Rankin, Stephen H Rankin, Andrew C Rankin
Journal of Molecular and Cellular Cardiology|September 23, 2006
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillationDavide Pau, Antony J Workman, Kathleen A Kane, et al.
British Journal of Pharmacology|November 19, 2003
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockadeDavide Pau, Antony J Workman, Kathleen A Kane, et al.
Pageof 3